• MGD Partnership
  • About LCC
  • Latest
  • Schedule a call
LCC Technologies Establishes Drug Discovery Collaboration Agreement with Stanford University to Advance Novel Small Molecule Therapeutics

LCC Technologies Establishes Drug Discovery Collaboration Agreement with Stanford University to Advance Novel Small Molecule Therapeutics

Through LCC’s data-driven small molecule discovery platform and Stanford researchers’ expertise in disease biology, the collaboration aims to identify new therapeutic strategies and accelerate them towards clinical evaluation. Press Release – Liverpool,...
Mayor welcomes XtalPi to the Liverpool City Region following landmark LCC acquisition

Mayor welcomes XtalPi to the Liverpool City Region following landmark LCC acquisition

Global AI‑robotics R&D leader deepens presence in the North West, spotlighting the region’s talent, innovation assets and investor‑ready sites. Press Release – Liverpool City Region, 23 March 2026 The Mayor of the Liverpool City Region Steve Rotheram has...
LCC Technologies announces CSO and CCO hires to accelerate strategic collaborations with biopharma partners

LCC Technologies announces CSO and CCO hires to accelerate strategic collaborations with biopharma partners

XtalPi acquires LCC to unlock unprecedented power in chemical space exploration

XtalPi acquires LCC to unlock unprecedented power in chemical space exploration

Press Release – Cambridge, Mass. and Liverpool, UK XtalPi, a leading life sciences and new materials R&D platform powered by quantum physics, AI and robotics, today announced its acquisition of Liverpool ChiroChem (LCC), a pioneer in automated chiral...

Recent Posts

  • LCC Technologies Establishes Drug Discovery Collaboration Agreement with Stanford University to Advance Novel Small Molecule Therapeutics
  • CheM62 Returns: The Heath in Runcorn Hosts the 2026 Conference 
  • Mayor welcomes XtalPi to the Liverpool City Region following landmark LCC acquisition
  • LCC Technologies announces CSO and CCO hires to accelerate strategic collaborations with biopharma partners
  • XtalPi and LCC shortlisted for Investment Deal of the Year at the BioNow Awards

Recent Comments

No comments to show.
  • Follow

Contact us

The Heath Business & Technical Park, Runcorn United Kingdom WA7 4QX
Telephone: +44 (0)1928 51 3101 Email: contact@lcctechnologies.com

© LCC – All rights reserved and asserted

Powered by
►
Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.
None
►
Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.
None
►
Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.
None
►
Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.
None
►
Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
None
Powered by